Global Orphan Drugs Market Insights, Forecast to 2025

Global Orphan Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Orphan Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Orphan Drugs Market Size Growth Rate by Product
1.4.2 Oncology
1.4.3 Gastrointestinal
1.4.4 Pulmonary
1.4.5 Neurology
1.4.6 Hematology
1.4.7 Cardio-vascular
1.4.8 Metabolic disorders
1.4.9 Endocrinology
1.4.10 Infectious diseases
1.4.11 Others
1.5 Market by End User
1.5.1 Global Orphan Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Orphan Drugs Market Size
2.1.1 Global Orphan Drugs Revenue 2014-2025
2.1.2 Global Orphan Drugs Sales 2014-2025
2.2 Orphan Drugs Growth Rate by Regions
2.2.1 Global Orphan Drugs Sales by Regions
2.2.2 Global Orphan Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Orphan Drugs Sales by Manufacturers
3.1.1 Orphan Drugs Sales by Manufacturers
3.1.2 Orphan Drugs Sales Market Share by Manufacturers
3.1.3 Global Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Orphan Drugs Revenue by Manufacturers
3.2.1 Orphan Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Orphan Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Orphan Drugs Price by Manufacturers
3.4 Orphan Drugs Manufacturing Base Distribution, Product Types
3.4.1 Orphan Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orphan Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Orphan Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Orphan Drugs Sales by Product
4.2 Global Orphan Drugs Revenue by Product
4.3 Orphan Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Orphan Drugs Breakdown Data by End User
6 North America
6.1 North America Orphan Drugs by Countries
6.1.1 North America Orphan Drugs Sales by Countries
6.1.2 North America Orphan Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Orphan Drugs by Product
6.3 North America Orphan Drugs by End User
7 Europe
7.1 Europe Orphan Drugs by Countries
7.1.1 Europe Orphan Drugs Sales by Countries
7.1.2 Europe Orphan Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orphan Drugs by Product
7.3 Europe Orphan Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Orphan Drugs by Countries
8.1.1 Asia Pacific Orphan Drugs Sales by Countries
8.1.2 Asia Pacific Orphan Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Orphan Drugs by Product
8.3 Asia Pacific Orphan Drugs by End User
9 Central & South America
9.1 Central & South America Orphan Drugs by Countries
9.1.1 Central & South America Orphan Drugs Sales by Countries
9.1.2 Central & South America Orphan Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Orphan Drugs by Product
9.3 Central & South America Orphan Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Orphan Drugs by Countries
10.1.1 Middle East and Africa Orphan Drugs Sales by Countries
10.1.2 Middle East and Africa Orphan Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Orphan Drugs by Product
10.3 Middle East and Africa Orphan Drugs by End User
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Orphan Drugs Products Offered
11.1.5 Novartis Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Company Business Overview
11.2.3 Bristol-Myers Squibb Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bristol-Myers Squibb Orphan Drugs Products Offered
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Company Business Overview
11.3.3 Celgene Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Celgene Orphan Drugs Products Offered
11.3.5 Celgene Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Company Business Overview
11.4.3 Roche Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Roche Orphan Drugs Products Offered
11.4.5 Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Orphan Drugs Products Offered
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sanofi Orphan Drugs Products Offered
11.6.5 Sanofi Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Alexion Pharmaceuticals Orphan Drugs Products Offered
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Company Business Overview
11.8.3 Eli Lilly Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Eli Lilly Orphan Drugs Products Offered
11.8.5 Eli Lilly Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Company Business Overview
11.9.3 Novo Nordisk Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Novo Nordisk Orphan Drugs Products Offered
11.9.5 Novo Nordisk Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 Company Business Overview
11.10.3 AstraZeneca Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AstraZeneca Orphan Drugs Products Offered
11.10.5 AstraZeneca Recent Development
11.11 Eisai
11.12 Daiichi Sankyo
11.13 Bayer
11.14 GlaxoSmithKline
11.15 Merck
11.16 Johnson & Johnson
11.17 Biogen
11.18 Shire
11.19 Amgen
12 Future Forecast
12.1 Orphan Drugs Market Forecast by Regions
12.1.1 Global Orphan Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Orphan Drugs Revenue Forecast by Regions 2019-2025
12.2 Orphan Drugs Market Forecast by Product
12.2.1 Global Orphan Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Orphan Drugs Revenue Forecast by Product 2019-2025
12.3 Orphan Drugs Market Forecast by End User
12.4 North America Orphan Drugs Forecast
12.5 Europe Orphan Drugs Forecast
12.6 Asia Pacific Orphan Drugs Forecast
12.7 Central & South America Orphan Drugs Forecast
12.8 Middle East and Africa Orphan Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orphan Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Orphan Drugs Product Picture
Table Orphan Drugs Market Segments
Table Key Manufacturers Orphan Drugs Covered
Table Global Orphan Drugs Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Orphan Drugs Sales Market Share by Product 2014-2025
Figure Oncology Product Picture
Table Major Manufacturers of Oncology
Figure Gastrointestinal Product Picture
Table Major Manufacturers of Gastrointestinal
Figure Pulmonary Product Picture
Table Major Manufacturers of Pulmonary
Figure Neurology Product Picture
Table Major Manufacturers of Neurology
Figure Hematology Product Picture
Table Major Manufacturers of Hematology
Figure Cardio-vascular Product Picture
Table Major Manufacturers of Cardio-vascular
Figure Metabolic disorders Product Picture
Table Major Manufacturers of Metabolic disorders
Figure Endocrinology Product Picture
Table Major Manufacturers of Endocrinology
Figure Infectious diseases Product Picture
Table Major Manufacturers of Infectious diseases
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Orphan Drugs Market Size Growth Rate by End User 2019-2025 (MT)
Figure Hospital Pharmacies
Figure Speciality Pharmacies
Figure Retail pharmacies
Figure Others
Figure Orphan Drugs Report Years Considered
Figure Global Orphan Drugs Market Size 2014-2025 (Million US$)
Figure Global Orphan Drugs Sales 2014-2025 (MT)
Table Global Orphan Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Orphan Drugs Sales by Regions 2014-2019 (MT)
Table Global Orphan Drugs Sales Market Share by Regions 2014-2019
Figure Global Orphan Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Orphan Drugs Sales Market Share by Regions
Table Global Orphan Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Orphan Drugs Revenue Market Share by Regions 2014-2019
Figure Global Orphan Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Orphan Drugs Revenue Market Share by Regions
Table Global Orphan Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Orphan Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Orphan Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Orphan Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Orphan Drugs Revenue Share by Manufacturers (2014-2019)
Figure Orphan Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Orphan Drugs Price (2014-2019) (USD/Kg)
Table Orphan Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Orphan Drugs Product Type
Table Date of International Manufacturers Enter into Orphan Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Orphan Drugs Sales by Product (2014-2019) (MT)
Table Global Orphan Drugs Sales Share by Product (2014-2019)
Figure Global Orphan Drugs Sales Market Share by Product (2014-2019)
Figure Global Orphan Drugs Sales Market Share by Product in 2018
Table Global Orphan Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Orphan Drugs Revenue Share by Product (2014-2019)
Figure Global Orphan Drugs Revenue Market Share by Product (2014-2019)
Figure Global Orphan Drugs Revenue Market Share by Product in 2018
Table Orphan Drugs Price by Product 2014-2019 (USD/Kg)
Table Global Orphan Drugs Sales by End User (2014-2019) (MT)
Table Global Orphan Drugs Sales Share by End User (2014-2019)
Figure Global Sales Orphan Drugs Market Share by End User (2014-2019)
Figure Global Sales Orphan Drugs Market Share by End User in 2018
Figure North America Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Orphan Drugs Sales by Countries (2014-2019) (MT)
Table North America Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Orphan Drugs Sales Market Share by Countries
Table North America Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Orphan Drugs Revenue Market Share by Countries
Figure United States Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure United States Orphan Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Canada Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Orphan Drugs Sales by Product (2014-2019) (MT)
Table North America Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Orphan Drugs Market Share by Product
Table North America Orphan Drugs Sales by End User (2014-2019) (MT)
Table North America Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Orphan Drugs Market Share by End User
Figure Europe Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Europe Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Orphan Drugs Sales Market Share by Countries
Table Europe Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Orphan Drugs Revenue Market Share by Countries
Figure Germany Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Germany Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Orphan Drugs Sales by Product (2014-2019) (MT)
Table Europe Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Orphan Drugs Market Share by Product
Table Europe Orphan Drugs Sales by End User (2014-2019) (MT)
Table Europe Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Orphan Drugs Market Share by End User
Figure Asia Pacific Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Sales Market Share by Countries
Table Asia Pacific Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Revenue Market Share by Countries
Figure China Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Singapore Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Orphan Drugs Sales by Product (2014-2019) (MT)
Table Asia Pacific Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Market Share by Product
Table Asia Pacific Orphan Drugs Sales by End User (2014-2019) (MT)
Table Asia Pacific Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Market Share by End User
Figure Central & South America Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Orphan Drugs Sales Market Share by Countries
Table Central & South America Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Orphan Drugs Revenue Market Share by Countries
Figure Brazil Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Argentina Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Orphan Drugs Sales by Product (2014-2019) (MT)
Table Central & South America Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Orphan Drugs Market Share by Product
Table Central & South America Orphan Drugs Sales by End User (2014-2019) (MT)
Table Central & South America Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Orphan Drugs Market Share by End User
Figure Middle East and Africa Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Sales Market Share by Countries
Table Middle East and Africa Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Revenue Market Share by Countries
Figure GCC Countries Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Turkey Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Orphan Drugs Sales by Product (2014-2019) (MT)
Table Middle East and Africa Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Market Share by Product
Table Middle East and Africa Orphan Drugs Sales by End User (2014-2019) (MT)
Table Middle East and Africa Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Market Share by End User
Table Novartis Company Details
Table Novartis Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celgene Company Details
Table Celgene Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Celgene Recent Development
Table Roche Company Details
Table Roche Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Alexion Pharmaceuticals Company Details
Table Alexion Pharmaceuticals Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Alexion Pharmaceuticals Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novo Nordisk Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Eisai Company Details
Table Daiichi Sankyo Company Details
Table Bayer Company Details
Table GlaxoSmithKline Company Details
Table Merck Company Details
Table Johnson & Johnson Company Details
Table Biogen Company Details
Table Shire Company Details
Table Amgen Company Details
Table Global Orphan Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Global Orphan Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Orphan Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Orphan Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Orphan Drugs Sales Forecast by Product 2019-2025 (MT)
Table Global Orphan Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Orphan Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Orphan Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Orphan Drugs Sales Forecast by End User 2019-2025 (MT)
Table Global Orphan Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Orphan Drugs Value Chain
Table Orphan Drugs Customers List
Table Orphan Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs